Lorenzo Rizzo
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Abstracts of the 36th World Congress on Ultrasound in Obstetrics and Gynecology, 4-7 September 2026, London, UK.
Journal: Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
Published: July 06, 2026
Association of hypomethylating agents + venetoclax in the real-life treatment of Myeloproliferative Neoplasms in blastic phase.
Journal: Leukemia research
Published: March 06, 2026
Intrapartum sonographic evaluation of fetal head descent in relation to maternal position: comparison between dorsal lithotomy and kneeling squat positions.
Journal: Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
Published: January 15, 2026
Outcome of adult acute myeloid leukemia patients with extramedullary disease and treatment with venetoclax/ hypomethylating agents.
Journal: Haematologica
Published: June 09, 2024
Immunomodulatory cytokines and clonal dynamics in low-risk myelodysplastic syndromes patients treated with luspatercept.
Journal: American journal of hematology
Published: June 30, 2023
Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 09, 2023
Luspatercept in combination with recombinant erythropoietin in patients with myelodysplastic syndrome with ring sideroblasts: Stimulating early and late-stage erythropoiesis.
Journal: European journal of haematology
Published: December 21, 2022
Myelodysplastic Syndromes with Isolated 20q Deletion: A New Clinical-Biological Entity?
Journal: Journal of clinical medicine
Published: March 01, 2022
Therapeutic Management of Patients with FLT3 + Acute Myeloid Leukemia: Case Reports and Focus on Gilteritinib Monotherapy.
Journal: Pharmacogenomics and personalized medicine
Published: October 28, 2021
Switching to an alternative recombinant erythropoietin agent in patients with myelodysplastic syndromes: a second honeymoon?
Journal: British journal of haematology
Published: June 01, 2021
Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients.
Journal: Annals of hematology
Published: January 06, 2021
Last Updated: 09/26/2026